Four member states including Poland say amended deal is not ‘fair solution’ to surplus of shots

Pfizer’s revised EU Covid vaccine contract meets resistance

Pfizer has offered to change its Covid-19 vaccine contract with the EU to cut the number of doses being supplied by 40 per cent and delay their delivery after member states complained of a glut of shots.
The US pharmaceutical company has agreed to extend its contract from 2023 to 2026, according to two people with knowledge of the talks. But it is insisting on payment for doses ordered in the contract that will never be manufactured, angering some governments.
This story originally appeared on: Financial Times - Author:Donato Paolo Mancini